Yu-pei P. Zhao

Peking Union Medical College Hospital, Peking Union Medical College
Beijing, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 166 publications

Short-term outcomes of robotic-assisted distal pancreatectomy using domestic KangDuo Surgical Robot-2000 System versus Da Vinci Xi system: a two-center prospective observational cohort study.

Short-term outcomes of robotic-assisted distal pancreatectomy using domestic KangDuo Surgical Robot-2000 System versus Da Vinci Xi system: a two-center prospective observational cohort study.

Journal: Surgical endoscopy
Published: April 20, 2026

Artificial intelligence: Catalyzing a new era in pancreatic cancer cure.

Artificial intelligence: Catalyzing a new era in pancreatic cancer cure.

Journal: Cancer letters
Published: February 06, 2026

TRDMT1-Mediated mRNA m5C Methylation Decreases Chemotherapy Sensitivity by Activating Homologous Recombination-Mediated DNA Damage.

TRDMT1-Mediated mRNA m5C Methylation Decreases Chemotherapy Sensitivity by Activating Homologous Recombination-Mediated DNA Damage.

Journal: Cancer letters
Published: February 03, 2026

Neutrophil extracellular traps induced by tumour-derived NGAL reprogram CAF subtypes via ITGA5 to promote tumour progression in pancreatic cancer.

Neutrophil extracellular traps induced by tumour-derived NGAL reprogram CAF subtypes via ITGA5 to promote tumour progression in pancreatic cancer.

Journal: Gut
Published: December 02, 2025

Nab-paclitaxel plus S-1 induction chemotherapy for patients with locally advanced pancreatic cancer: a multicenter, open-label phase 2 study.

Nab-paclitaxel plus S-1 induction chemotherapy for patients with locally advanced pancreatic cancer: a multicenter, open-label phase 2 study.

Journal: Signal transduction and targeted therapy
Published: November 21, 2025

Spatial multi-omics defines cancer-associated fibroblasts subtype gradients driving metabolic support and immune remodeling in pancreatic ductal adenocarcinoma.

Spatial multi-omics defines cancer-associated fibroblasts subtype gradients driving metabolic support and immune remodeling in pancreatic ductal adenocarcinoma.

Journal: Cancer letters
Published: October 22, 2025

Impact of precise preoperative vascular assessment and different dorsal pancreatic artery variant subtypes on pancreatic surgery-related bleeding.

Impact of precise preoperative vascular assessment and different dorsal pancreatic artery variant subtypes on pancreatic surgery-related bleeding.

Journal: BMC gastroenterology
Published: August 28, 2025

Spatial transcriptomics defines the molecular progression, invasion and immune landscape of IPMN and IPMN-derived pancreatic cancer.

Spatial transcriptomics defines the molecular progression, invasion and immune landscape of IPMN and IPMN-derived pancreatic cancer.

Journal: Gut
Published: June 10, 2025

FOLR2+ macrophages in cancer: allies or enemies.

FOLR2+ macrophages in cancer: allies or enemies.

Journal: Cell communication and signaling : CCS
Published: April 07, 2025

Decipher the single-cell level responses to chemotherapy in pancreatic ductal adenocarcinoma by a cross-time context graph model.

Decipher the single-cell level responses to chemotherapy in pancreatic ductal adenocarcinoma by a cross-time context graph model.

Journal: Cancer letters
Published: March 13, 2025

Targeting metabolic-epigenetic-immune axis in cancer: molecular mechanisms and therapeutic implications.

Targeting metabolic-epigenetic-immune axis in cancer: molecular mechanisms and therapeutic implications.

Journal: Signal transduction and targeted therapy
Published: February 16, 2025

Microbiome, metabolome, and ionome profiling of cyst fluids reveals heterogeneity in pancreatic cystic neoplasms.

Microbiome, metabolome, and ionome profiling of cyst fluids reveals heterogeneity in pancreatic cystic neoplasms.

Journal: Cancer letters
Published: December 03, 2024
Showing 1-12 of 166

Last Updated: 09/26/2026